Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:688576's PB Ratio is ranked better than 65.57% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 2.04
vs SHSE:688576: 1.43
During the past 12 months, Chongqing Xishan Science and Technology Co's average Book Value Per Share Growth Rate was 2.80% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 54.90% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 70.30% per year.
During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of Chongqing Xishan Science and Technology Co was 141.10% per year. The lowest was 25.50% per year. And the median was 59.00% per year.
Back to Basics: PB Ratio
Chongqing Xishan Science and Technology Co (SHSE:688576) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Chongqing Xishan Science and Technology Co PB Ratio Related Terms
Chongqing Xishan Science and Technology Co PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chongqing Xishan Science and Technology Co PB Ratio Chart
Chongqing Xishan Science and Technology Co Annual Data
SHSE:688576 vs ISRG, BDX, MDLN: PB Ratio Comparison
For the Medical Instruments & Supplies subindustry, Chongqing Xishan Science and Technology Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chongqing Xishan Science and Technology Co PB Ratio vs Medical Devices & Instruments Industry
Chongqing Xishan Science and Technology Co PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Chongqing Xishan Science and Technology Co (SHSE:688576) has a PB Ratio of 1.43 as of Jul. 29, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Chongqing Xishan Science and Technology Co and its competitors. This is 22% below median its historical median of 1.84. Over the past decade, Chongqing Xishan Science and Technology Co's PB Ratio has ranged from 1.26 to 18.08. According to the industry distribution chart, Chongqing Xishan Science and Technology Co ranks #271 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 34.4%.
Is Chongqing Xishan Science and Technology Co's PB Ratio too high?
Chongqing Xishan Science and Technology Co's current PB Ratio of 1.43 is 22% below median its 10-year median of 1.84. Over the past 10 years, this metric has ranged from a low of 1.26 to a high of 18.08. The Medical Devices & Instruments industry median PB Ratio is 2.04. Chongqing Xishan Science and Technology Co's value of 1.43 is 29.9% below this industry median. Based on the distribution chart, Chongqing Xishan Science and Technology Co ranks #271 out of 787 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Chongqing Xishan Science and Technology Co has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chongqing Xishan Science and Technology Co's PB Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Chongqing Xishan Science and Technology Co ranks #271 out of 787 companies for PB Ratio. This puts Chongqing Xishan Science and Technology Co in the upper half of its industry. The industry median PB Ratio is 2.04. Chongqing Xishan Science and Technology Co's value of 1.43 is 29.9% below this benchmark. Historically, Chongqing Xishan Science and Technology Co's own PB Ratio has ranged from 1.26 to 18.08 over the past decade. While the company's 10-year median is 1.84 vs. the industry median of 2.04, Chongqing Xishan Science and Technology Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.04, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chongqing Xishan Science and Technology Co's current PB Ratio of 1.43 is 29.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Chongqing Xishan Science and Technology Co and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chongqing Xishan Science and Technology Co's current PB Ratio is 1.43, which is 22% below median its own 10-year median of 1.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chongqing Xishan Science and Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Chongqing Xishan Science and Technology Co (SHSE:688576) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥53.68, compared to a current price of ¥36.81 — trading 31.4% below its estimated fair value. The current PB Ratio is 1.43, which is 22% below median its 10-year median of 1.84 and 29.9% below the Medical Devices & Instruments industry median of 2.04. Chongqing Xishan Science and Technology Co's overall GF Score™ is 85/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Chongqing Xishan Science and Technology Co (SHSE:688576), the current PB Ratio is 1.43 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chongqing Xishan Science and Technology Co (SHSE:688576) Overvalued in 2026?
Based on GuruFocus' analysis, Chongqing Xishan Science and Technology Co stock appears to be undervalued.
The current stock price of ¥36.81 is trading 31.4% below its estimated GF Value™ of ¥53.68.
GuruFocus considers Chongqing Xishan Science and Technology Co to be Significantly Undervalued.
Key valuation signals for SHSE:688576:
PB Ratio: 1.43 (22% below median its 10-year median of 1.84)
GF Value™: ¥53.68 vs. price of ¥36.81 (31.4% below fair value)
Industry Position: 29.9% below the Medical Devices & Instruments median (#271 of 787)
No single metric tells the full story. See the SHSE:688576 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chongqing Xishan Science and Technology Co Business Description
AddressNo. 9, Middle Section of Huangshan Avenue, Jupiter Science and Technology Development Center, High-tech Park, North New District, Chongqing, CHN, 401121
Chongqing Xishan Science and Technology Co Ltd focuses on surgical instruments, especially in the field of minimally invasive surgical instruments. It is mainly engaged in the research, development, production and sales of minimally invasive surgical instruments. Speculum, energy surgery equipment and other products, currently the products are mainly used in neurosurgery, ENT, orthopedics, breast surgery and other clinical departments. The company's main products are surgical power units, consumables and accessories, which are mainly used for cutting, grinding, planing, sawing, milling and trimming of bone tissue and soft tissue in surgical operations, especially minimally invasive surgical operations.
85GF Score
Get the complete analysis for SHSE:688576
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688576 has been successfully added to your 
